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ABSTRACT
Objectives: Laparoscopic cholecystectomy (LC) combined
with endoscopic retrograde cholangiopancreatography
(ERCP) has been widely used in the management of the
acute biliopancreatic pathology. Nevertheless, controversy
remains about the appropriate timing for retrograde
cholangiopancreatography.
Methods: A retrospective study was undertaken on a con-
secutive series of 117 patients with acute biliary-pancreatic
pathology, who underwent laparoscopic cholecystectomy
between April 1995 and April 1999. Criteria for preopera-
tive endoscopic retrograde cholangiopancreatography
were defined, and the patients were divided into 3 groups
based on the presence or absence of a preoperative retro-
grade cholangiopancreatography indication: (1) ERCP+LC
group: patients with retrograde cholangiopancreatography
indicated and performed (n = 30); (2) LC group: patients
without retrograde cholangiopancreatography criteria treat-
ed only by LC (n = 47); (3) LC-ERCP group: patients with
retrograde cholangiopancreatography criteria but not per-
formed (n = 40).
Results: The groups were similar in age, sex, ASA, and
clinical diagnosis. No statistical differences occurred in
operative times (73.8 min, 68 min, 67 min), major compli-
cations (3.3%, 4.25%, 12.5%), and mean postoperative stay
(3.7 ± 4; 4.7 ± 2; 5.7 ± 2). Postoperative retrograde cholan-
giopancreatography had to be used, respectively, in 0%,
10.6%, and 7.5%. The best predictive criteria for common
bile duct pathology were choledocholithiasis on an ultra-
sound scan and the presence of cholangitis. The other cri-
teria tested had a low predictive value.
Conclusions: Preoperative endoscopic retrograde cholan-
giopancreatography followed by early laparoscopic chole-
INTRODUCTION
It has been soundly established that laparoscopic cholecys-
tectomy (LC) can be performed safely in patients with acute
biliary-pancreatitis.1-4 Discussion persists, however, about
the appropriate timing for endoscopic retrograde cholan-
giopancreatography (ERCP) and when it is indicated.
In recent years, different studies have advocated early ERCP
before LC.5,6 However, many centers still prefer a more con-
servative approach, keeping this diagnostic/therapeutic tool
for postoperative complications.7,8 Three main reasons exist
for this type of management. First, many surgeons believe
that early preoperative ERCP can worsen the process.
Second, it has been postulated that many patients experi-
ence spontaneous passage of choledochal stones, making
ERCP unnecessary. The third reason is the increased in-hos-
pital stay, which is necessary with preoperative ERCP.
The objective of this study was to retrospectively compare
the safety and effectiveness of preoperative versus selective
postoperative ERCP in the management of patients with
acute biliopancreatic pathology (ABPP).
MATERIALS AND METHODS
Between April 1995 and April 1999, a consecutive series of
117 symptomatic patients with ABPP were admitted to our
center. All patients were investigated with a full blood
count, liver function test, amylase, urea, electrolytes, coag-
ulation, and conventional radiology. An ultrasound scan
was performed between 24 and 48 hours after admission.
When used, preoperative ERCP was performed between 24
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cystectomy can be performed safely in acute biliary-pan-
creatic pathology, avoiding 2-stage treatment of these
patients and minimizing hospital stay and inconvenience to
the patients. Nevertheless, this therapeutic/diagnostic tool
must be used selectively.
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and 96 hours after admission. As soon as all these tests were
completed, surgery was performed according to the stan-
dard laparoscopic technique. Intraoperative cholangiogra-
phy was not used. All the patients were treated in 1 stage,
in an urgent way (<72 hours after onset of symptoms) or
intermediately (>72 hours after onset of clinical manifesta-
tions), without a delay in elective LC.
To develop a retrospective study, criteria for preoperative
ERCP were defined and included all patients with pancre-
atitis, cholangitis, an abnormal liver function test (ALFT),
dilated common bile duct (DCBD), and choledocholithiasis.
Based on these criteria, the patients were divided into 3
groups: (1) ERCP+LC group: patients in which preoperative
ERCP was indicated and performed before LC (n = 30); (2)
LC group: patients without ERCP criteria treated by LC (n =
47); (3) LC-ERCP group: patients with ERCP criteria but treat-
ed alone by LC (n = 40).
Statistical Analysis
Nonparametric data were analyzed with the Mann-Whitney
U test for discrete variables. The complications were com-
pared with the Fisher exact test. A p value <0.05 was regard-
ed as significant.
RESULTS
No difference existed in age, sex ratio, and American Society
of Anesthesiologists’ (ASA) classifications of the series
(Table 1). The clinical presentation of the 3 groups is shown
in Table 2. As would be expected, evident differences exist-
ed in the LC group versus the 2 others. 
Hospital stay and operative times are shown in Table 3. No
differences occurred in mean operative time and mean post-
operative stay, but total hospital stay was longer in the ERCP
+ LC group (p < 0.0001) and in the ERCP-LC group (p <
0.07) versus the LC group.
Preoperative ERCP was performed between 24 and 96
(mean 78.4) hours after admission. The findings of the
cholangiogram are shown in Table 4. All ERCP procedures
were successfully completed. Two cases of upper gastroin-
testinal bleeding (UGB) occurred as complications of this
technique. The mean delay between preoperative ERCP
and LC was 4.6 days.
One death occurred in the ERCP+LC group (3%) due to
intraperitoneal bleeding after surgery complicated with
adult respiratory distress syndrome (ADRS). Major and
minor complications are cited in Table 5. The incidence of
major complications was 4.25% in the LC group (1 case of
biliary fistula and 1 of retained stones), 12.56% in the ERCP-
LC group (2 biliary fistula, 2 bile duct injuries, and 1 case of
intraabdominal abscess), and 3.3% (hemoperitoneum) in
the ERCP+LC group. In 6 cases (5.25%), the laparoscopic
procedure was converted to open surgery.
In the ERCP+LC group, 16 (53.3%) of 30 preoperative ERCP
patients had positive findings (choledocholithiasis), and if
we consider patients with papillitis and biliary sludge, the
total incidence of common bile duct (CBD) pathology is
about 70%. However, when we considered the relative
value of each individual criterion to serve as a CBD pathol-
ogy predictor, choledocholithiasis on an ultrasound scan
had an effectiveness of 83%; and in the case of cholangitis,
it was 100%. The value of the other criteria used was abnor-
mal liver function test, 66.6%; dilated common bile duct,
33.3%; and pancreatitis, 28.6%. This aspect did not change
significantly (46%) when pancreatitis was associated with
ALFT.
Three (7.5%) patients in the LC-ERCP group needed post-
operative treatment with ERCP: choledocholithiasis, papilli-
tis, and biliary fistula were the indications. In the LC group,
5 patients (10.6%) required postoperative ERCP, 3 for chole-
docholithiasis, 1 for papillitis, and 1 for biliary fistula. In the
Table 1.
Patient Status
Group Age Sex Ratio ASA I ASA II ASA III ASA IV
(yr/median) (F/M)
ERCP + LC 69.25 15/15 13 12 5 0
LC 61.92 34/13 22 21 4 0
LC - ERCP 62.5 24/16 16 21 3 0
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Table 2.
Clinical Presentation
ERCP + LC LC LC - ERCP
Pancreatitis 7 (23.3%) 0 9 (22.5%)
Cholecystitis 7 (23.3%) 31 (66%) 15 (37.5%)
Obstructive jaundice  9 (30%) 0 0
Cholecystopancreatitis 5 (16.6%) 0 11 (27.5%)
Biliary colic 0 16 (34%) 5 (12.5%)
Cholangitis 2 (6.6%) 0 0
Table 3.
Operative Time and Length of Stay
ERCP + LC LC LC - ERCP
Operating time (min)* 73.8 ± 27 68 ± 778 67 ± 511
Postoperative hospital stay (days)* 3.7 ± 4 4.7 ± 2 5.7 ± 2
Total hospital stay (days)† 10.8 ± 3 8.4 ± 3  10.46 ± 40.0001
*p = ns.
†ERCP+LC vs LC, p = 0.0001; LC-ERCP vs LC, p = 0.07.
Table 4.
Preoperative ERCP
ERCP Criteria Cholangiogram Treatment*
Pancreatitis (7) Papillitis (4) SP
Choledocholithiasis (2) SP + CBD clearance
Papillitis + biliary sludge (1)  SP + CBD clearance
ALFT (6) Papillitis (1) SP
Choledocholithiasis (4) SP + CBD clearance
Papillitis + biliary sludge (1) SP + CBD clearance
Choledocholithiasis (6) Choledocholithiasis (5) SP + CBD clearance
Papillitis + biliary sludge (1) SP + CBD clearance
DCBD (9) Papillitis (4) SP
Choledocholithiasis (3) SP + CBD clearance
Papillitis + biliary sludge (2) SP + CBD clearance
Cholangitis (2) Choledocholithiasis (2) SP + CBD clearance
*SP = sphincterotomy
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ERCP+LC group, no patients required postoperative ERCP.
DISCUSSION
Laparoscopic cholecystectomy appears to be a safe and
cost-effective treatment option for acute biliary-pancreatic
pathology (ABPP) management.2,3,9 However, the role and
timing of ERCP in these patients remains controversial.7,10,11
In biliary-pancreatic surgery for benign conditions, options
include pre- and postoperative ERCP. An NIH Consensus
statement recommends preoperative ERCP based on suspi-
cion of CBD stones.12 However, ABPP supports special fea-
tures. In recent years, the indications for preoperative ERCP
have been amplified to include cholangitis, pancreatitis,
ALFT, and DCBD in ultrasound scans.10,11,13 Some of these
are accepted by most authors and institutions, but others
like pancreatitis, DCBD, and ALFT are discussed.7,10,11
The main problem in establishing some concrete criteria
resides in the fact that they have an excellent negative pre-
dictive value so that patients without them will be free of
CBD pathology in about 90% to 92% of cases,14,15 92.3% in
our series. Nevertheless, their positive predictive value is
inferior, between 15% and 58%.15,16 In our series, we found
in the ERCP+LC group an incidence of choledocholithiasis
of 53.3%. The only good predictive factors for CBD pathol-
ogy and thus a good indicator for preoperative ERCP were
choledocholithiasis in an ultrasound scan, confirmed with
ERCP in the 83% of patients, and cholangitis (100% associ-
ated with choledocholithiasis). The value of the other crite-
ria used was significantly lower: pancreatitis 28.6%, ALFT
66.6%, and DCBD 33.3%. This suggests that approximately
50% of the ERCP procedures were unnecessary.
Therefore, we are in agreement with those authors who
recommend more restrictive criteria for preoperative ERCP
in these patients.7,10,17 Probably in patients with moderate
gallstone pancreatitis, without cholangitis, and with a non-
persistent or a moderate increase in liver function tests,
selective postoperative ERCP will be a better option,
decreasing hospital stay and medical costs and saving
unnecessary endoscopic procedures. The same conclusion
could be applied to DCBD criteria.
Furthermore, in our series, when we compared the out-
come of the patients included in the ERCP+LC and LC-ERCP
groups, the accomplishment of the preoperative ERCP
based on these 3 criteria (pancreatitis, ALFT, DCBD) does
not seem to modify the evolution of the process. Moreover,
in the LC-ERCP group, no patients were admitted with a
diagnostic suspicion of choledocholithiasis and cholangitis,
only 3 (7.5%) needed postoperative ERCP. This confirms
that pancreatitis, DCBD, and ALFT are not very useful as cri-
Table 5.
Postoperative Complications
ERCP+LC LC LC-ERCP P Value
Major complications
Retained stones 0 1 0 ns
Bile duct injury 0 0 2 ns
Biliary fistula 0 1 2 ns
Intraabdominal abscess 0 0 1 ns
Hemoperitoneum 1 0 0 ns
Minor complications
Bilioma 0 1 0 ns
Atelectasis 2 2 0 ns
Upper gastrointestinal bleeding 2 0 2 ns
Heart failure 0 0 2 ns
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If we consider the observations made in the ERCP+LC and
LC groups, it is evident that the only variable negatively
affected by preoperative ERCP is the total hospital stay. This
is another reason to restrict the procedure when it is not
soundly indicated.
Surgical treatment of choledocholithiasis was not carried out
because all ERCP procedures (preoperative and postopera-
tive) were successfully completed and the CBDs could be
cleared. At any rate, we usually do not approach choledo-
cholithiasis with laparoscopic surgery.
CONCLUSION
In the same way as several previous reports,10,14 our data
show that selection of preoperative ERCP based on specif-
ic criteria leads to acceptable results and is a valuable
option for management of acute biliary pathology, but
ERCP should be performed selectively. Based on our obser-
vations as well as those of others, our selection criteria for
preoperative ERCP have become stricter over time, and
have been restricted to choledocholithiasis and acute
cholangitis. 
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